Literature DB >> 6655710

Plasma and myocardial levels of cefonicid during open-heart surgery.

R P Sterling, D J Connor, J C Norman.   

Abstract

To minimize the incidence of postoperative infections in patients undergoing open-heart surgery, antibiotics should maintain tissue concentrations greater than the minimal inhibitory concentration (MIC) for potential pathogens (eg, Staphylococcus) for the duration of the operation. The ability of cefonicid, a new β-lactamase-resistant parenteral cephalosporin, to attain plasma and myocardial levels greater than the MIC (4.8 to 5.0 μg/mL) for penicillin-resistant Staphylococci was assessed in 13 patients. Six patients were administered 1 g and seven patients were administered 2 g of cefonicid IM one hour prior to surgery. In all patients the plasma concentrations of the drug were determined at the start of surgery, 15 minutes after the patient was placed on cardiopulmonary bypass (CPB), and at the completion of CPB. In addition, the concentration of cefonicid was determined in a right atrial biopsy. It was found that both 1 g and 2 g of cefonicid administered one hour prior to surgery resulted in plasma and myocardial levels greater than the MIC for the organisms most frequently implicated in postoperative infections.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6655710      PMCID: PMC2609779     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  24 in total

1.  Sternal and costochondral infections following open-heart surgery. A review of 2,594 cases.

Authors:  A T Culliford; J N Cunningham; R H Zeff; O W Isom; P Teiko; F C Spencer
Journal:  J Thorac Cardiovasc Surg       Date:  1976-11       Impact factor: 5.209

2.  The effective period of preventive antibiotic action in experimental incisions and dermal lesions.

Authors:  J F Burke
Journal:  Surgery       Date:  1961-07       Impact factor: 3.982

3.  A double-blind clinical trial of prophylactic antibiotics in hip fractures.

Authors:  R J Boyd; J F Burke; T Colton
Journal:  J Bone Joint Surg Am       Date:  1973-09       Impact factor: 5.284

4.  Sources of contamination in open heart surgery.

Authors:  R M Kluge; F M Calia; J S McLaughlin; R B Hornick
Journal:  JAMA       Date:  1974-12-04       Impact factor: 56.272

5.  Prosthetic valvular endocarditis. A 12-year review.

Authors:  L Slaughter; J E Morris; A Starr
Journal:  Circulation       Date:  1973-06       Impact factor: 29.690

6.  Infection by air-borne bacteria with cardiopulmonary bypass.

Authors:  W S Blakemore; G J McGarrity; R J Thurer; H W Wallace; H MacVaugh; L L Coriell
Journal:  Surgery       Date:  1971-12       Impact factor: 3.982

7.  Cephaloridine prophylaxis in open heart surgery.

Authors:  M A Manko; N C Birkhead; T Bodi; J C Donnelly; G J Haupt
Journal:  Curr Ther Res Clin Exp       Date:  1972-10

8.  Bacterial endocarditis occurring after open-heart surgery.

Authors:  R S Fraser; R E Rossall; J Dvorkin
Journal:  Can Med Assoc J       Date:  1967-06-17       Impact factor: 8.262

9.  Antibiotic prophylaxis for open-heart surgery.

Authors:  P D Myerowitz; K Caswell; W G Lindsay; D M Nicoloff
Journal:  J Thorac Cardiovasc Surg       Date:  1977-04       Impact factor: 5.209

10.  Cephalothin prophylaxis in cardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens.

Authors:  D A Goldmann; C C Hopkins; A W Karchmer; R M Abel; M T McEnany; C Akins; M J Buckley; R C Moellering
Journal:  J Thorac Cardiovasc Surg       Date:  1977-03       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.